Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study is being carried out to determine the effect of dapagliflozin on cardiovacular outcomes when added to current background therapy in patients with type 2 diabetes with either established cardiovacular disease or cardiovascular risk factors.
Critère d'inclusion
- Diabetes Mellitus, Non-insulin Dependent,High Risk for Cardiovascular Event